Biotechs such as Gilead (NASDAQ:GILD) and Vertex Pharma (NASDAQ:VRTX), with a high local tax bill, a heavy U.S.-based ...

VRTX has recorded a positive one-day return after earnings in 58% of instances. When the return is positive, the median ...

Amid a reckoning for the gene therapy field, Vertex Pharmaceuticals has joined a growing list of companies paring back their ...

The new campaign stars former NFL quarterback Alex Smith, whose leg injury during a 2018 game led to a case of ...

The stock's fall snapped a seven-day winning streak.

Retired NFL quarterback Alex Smith is helping others through the 'taboo' of pain after nearly dying from a leg injury in 2018 ...

Analysts anticipate Vertex Pharmaceuticals to report an earnings per share (EPS) of $4.31. Anticipation surrounds Vertex Pharmaceuticals's announcement, with investors hoping to hear about both ...

A recent decision from the United States District Court for the District of Columbia continues to give significant deference ...

Shares of Vertex Pharmaceuticals Inc. VRTX advanced 1.41% to $503.50 Tuesday, on what proved to be an all-around great ...

Vertex Pharmaceuticals (VRTX) reachead $509.47 at the closing of the latest trading day, reflecting a +1.19% change compared to its last close. Looking beyond Wall Street's top -and-bottom-line ...

The European Medicines Agency has recommended marketing approval for Alyftrek for cystic fibrosis and Attrogy for a form of ...